Burkitt's Lymphoma of the NIH study found low-intensity therapy is very effective

Known as an excellent long term survival rate have of adult patients with burkitt's lymphoma cancer type-90% or more-treated with low intensity regimen, according to the discovery of a new clinical trial in below. Burkitt's lymphoma is the most aggressive type of lymphoma cancer begins in the cells of the immune system.

View the original article here